metricas
covid
Buscar en
Enfermedades Infecciosas y Microbiología Clínica
Toda la web
Inicio Enfermedades Infecciosas y Microbiología Clínica Legionella pneumophila serogrupo 1
Información de la revista
Vol. 21. Núm. 8.
Páginas 391-393 (enero 2003)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 21. Núm. 8.
Páginas 391-393 (enero 2003)
Acceso a texto completo
Legionella pneumophila serogrupo 1
Visitas
8373
Miguel Sabrià1
Autor para correspondencia
msabria@ns.hugtip.scs.es

Dr. M. Sabrià. Jefe de la Unidad de Enfermedades Infecciosas. Hospital Universitario Germans Trias i Pujol. Ctra. del Canyet, s/n. 08916 Badalona. Barcelona. España
Unidad de Enfermedades Infecciosas. Hospital Universitario Germans Trias i Pujol. Badalona. Barcelona. España.
Este artículo ha recibido
Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
D.W. Fraser, T.R. Tsai, W. Orenstein, W.E. Parkin, H.J. Beecham, R.G. Sharrar, et al.
Legionnaires’ disease: Description of an epidemic of pneumonia.
N Engl J Med, 297 (1977), pp. 1189-1197
[2.]
J.R. Benito, M. Montejo, L. Cancelo, R. Zalacaín, L. López, J. Fernández, et al.
Neumonía comunitaria por Legionella pneumophila serogrupo 1. Estudio de 97 casos.
Enferm Infecc Microbiol Clin, 21 (2003), pp. 394-400
[3.]
C. Josep.
Surveillance of Legionnaires’disease in Europe.
Legionella, pp. 311-317
[4.]
G. Carmona, N. Cardeñosa, A. Domínguez, L. Salleras.
Epidemiología descriptiva de la legionelosis. Cataluña 1997-2000.
Med Clin (Barc), 119 (2002), pp. 25-28
[5.]
J.A. Domínguez, J.M. Manterola, R. Blavia, N. Sopena, F.J. Belda, E. Padilla, et al.
Detection of Legionella pneumophila serogroup 1 antigen in nonconcentrated urine and urine concentrated by selective ultrafiltration.
J Clin Microbiol, 34 (1996), pp. 2334-2336
[6.]
Anónimo. Public Health Laboratory Service. Legionnaires’ disease cases. England and Wales residents, nosocomial, travel and community acquired 1980-1999. http://www.phls.co.uk/facts/Legionella/leginNosTravCom.htm
[7.]
A.L. Benin, R.F. Benson, R.E. Besser.
Trends in legionnaires disease, 1980-1998: Declining mortality and new patterns of diagnosis.
Clin Infect Dis, 35 (2002), pp. 1039-1046
[8.]
V.L. Yu, J.F. Plouffe, M.C. Pastoris, J.E. Stout, M. Schousboe, A. Widmer, et al.
Distribution of Legionella species and serogroups isolated by culture in patients with sporadic community-acquired legionellosis: An international collaborative survey.
J Infect Dis, 186 (2002), pp. 127-128
[9.]
N. Sopena, M. Sabrià, M.L. Pedro-Botet, J.M. Manterola, L. Matas, J. Domínguez, et al.
Prospective study of community-acquired pneumonia of bacterial etiology in adults.
Eur J Clin Microbiol Infect Dis, 18 (1999), pp. 852-858
[10.]
E.N. Vergis, A. Indorf, T.M. File, J. Phillips, J. Bates, J. Tan, et al.
Azithromycin vs cefuroxime plus erythromyciun for empirical treatment of community-acquired pneumonia in hospitalized patients.
Arch Intern Med, 160 (2000), pp. 1294-1300
[11.]
R.D. Helms.
Legionnaires’disease. Aspects of nosocomial infection.
Am J Med, 76 (1984), pp. 657-663
[12.]
M.L. Pedro-Botet, M. Sabrià, M. Haro, C. Rubio, G. Giménez, N. Sopena, et al.
Nosocomial and community-acquired Legionella pneumonia: clinical comparative analysis.
Eur Respir J, 8 (1995), pp. 1929-1933
[13.]
M. Ruiz, S. Ewing, M.A. Marcios, J. Martínez, F. Aranciia, J. Mensa, et al.
Etiology of community-acquired pneumonia. Impact og age, comorbidity and severity.
Am J Respiratory and Critial Care Med, 160 (1999), pp. 397-405
[14.]
N. Sopena, M. Sabrià, M.L. Pedro-Botet, E. Padilla, J. Domínguez, J. Morera, et al.
Comparative study of the clinical presentation of Legionella pneumonia and other community-acquired pneumonias.
Chest, 113 (1998), pp. 1195-1200
[15.]
V.L. Yu, F.J. Kroboth, J. Shonnard, A. Brown, S. McDearman, M. Magnussen.
Legionnaires’ disease: New clinical perspective from a prospective pneumonia study.
Am J Med, 73 (1982), pp. 357-361
[16.]
W.L. Straus, J.F. Plouffe, T.M. Jr. File, H.B. Lipman, B.H. Hackman, S.J. Salstrom, et al.
Ohio Legionnaires Disease Group.
Arch Intern Med, 156 (1996), pp. 1685-1692
[17.]
A. Granados, D. Podzamczer, F. Gudiol, F. Manresa.
Pneumonia due to Legionella pneumophila and pneumococcal pneumonia: Similarities and differences on presentation.
Eur Respir J, 2 (1989), pp. 130-134
[18.]
J. Roig, X. Aguilar, J. Ruiz, C. Domingo, E. Mesalles, J. Manterola, et al.
Comparative study of Legionella pneumophila and other nosocomial-acquired pneumonias.
Chest, 99 (1991), pp. 344-350
[19.]
B.A. Cunha.
Clinical features of legionnaires’ disease.
Semin Respir Infect, 13 (1998), pp. 116-127
[20.]
S.K. Gupta, T.F. Imperiale, G.A. Sarosi.
Evaluation of the Winthrop-University Hospital criteria to identify Legionella pneumonia.
Chest, 120 (2001), pp. 1064-1071
[21.]
A. Torres, J. Serra-Batlles, A. Ferrer, P. Jiménez, R. Celis, E. Cobo, et al.
Severe community-acquired pneumonia. Epidemiology and prognostic factors.
Am Rev Respir Dis, 144 (1991), pp. 312-318
[22.]
J. Pachón, M.D. Prados, F. Capote, J.A. Cuello, J. Garnacho, A. Verano.
Severe community-acquired pneumonia. Etiology, prognosis, and treatment.
Am Rev Respir Dis, 142 (1990), pp. 369-373
[23.]
V. Falcó, T. Fernández de Sevilla, J. Alegre, A. Ferrer.
Martínez Vázquez JM. Legionella pneumophila. A cause of severe community-adquired pneumonia.
Chest, 100 (1991), pp. 1007-1011
[24.]
B. Álvarez-Sánchez, F. Álvarez-Lerma, R. Jordá, J. Serra, M.J. López Cambra, M.D. Sandar.
Prognostic factors and etiology in patients with severe community-acquired pneumonia admitted at the ICU. Spanish multicenter study. Study Group on Severe Community-Acquired Pneumonia in Spain.
Med Clin (Barc), 111 (1998), pp. 650-654
[25.]
M. Sabria, V.L. Yu.
Hospital-acquired legionellosis: Solutions for a preventable infection.
The Lancet Infectious Diseases, 2 (2002), pp. 368-373
[26.]
N. Sopena, M. Sabria, M.L. Pedro-Botet, E. Reynaga, M. García-Núñez, J. Domínguez, L. Matas.
Factors related to persistence of legionella urinary antigen excretion in patients with legionnaires’ disease.
Eur J Clin Microbiol Infect Dis, 21 (2002), pp. 845-848
[27.]
J. Roig, M. Sabria, M.L. Pedro-Botet.
Legionella spp.: Community acquired and nosocomial infections.
Curr Opin Infect Dis, 16 (2003), pp. 145-151
[28.]
M.L. Pedro-Botet, M. Sabria-Leal, N. Sopena, J.M. Manterola, J. Morera, R. Blavia, et al.
Role of immunosuppression in the evolution of Legionnaires’ disease.
Clin Infect Dis, 26 (1998), pp. 14-19
Copyright © 2003. Elsevier España, S.L.. Todos los derechos reservados
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos